Viewing StudyNCT02631447



Ignite Creation Date: 2024-05-06 @ 7:58 AM
Last Modification Date: 2024-10-26 @ 11:54 AM
Study NCT ID: NCT02631447
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2015-12-09

Brief Title: Sequential Combo Immuno and Target Therapy SECOMBIT Study
Sponsor: Fondazione Melanoma Onlus
Organization: Fondazione Melanoma Onlus

Conditions & Keywords Data

Conditions:
Name
Metastatic Melanoma
Keywords:
Name View
BRAF mutation View
Metastatic Melanoma View